trial · primary record
MC001
Pancreatic Ductal Adenocarcinoma (PDAC)
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 40 |
| Primary completion | 2029-01 |
| Primary endpoint | Number of Participants With Treatment-Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs) |
| Registry ID | NCT07909356 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:46:35.094Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07909356
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.